Chaudhary Kleem 4
4 · Checkmate Pharmaceuticals, Inc. · Filed Dec 23, 2020
Insider Transaction Report
Form 4
Chaudhary Kleem
Chief Business Officer
Transactions
- Exercise/Conversion
Common Stock
2020-12-22$2.62/sh+4,000$10,480→ 4,000 total - Exercise/Conversion
Stock Option (right to buy)
2020-12-22−4,000→ 101,508 totalExercise: $2.62Exp: 2029-11-13→ Common Stock (4,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to such option vested and became exercisable on November 1, 2020 with the remainder to vest in substantially equal monthly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date. This option was initially for 105,508 shares and the Reporting Person has exercised his option to purchase 4,000 shares.